Who Are Our Supporters?
Early Check was initially supported by the National Institutes of Health (NIH) through the National Center for Advancing Translational Sciences program. It received $5 million to launch and sustain the program statewide for the first five years.
Early Check is supported by a public-private partnership.
Current Supporters:
Principal Supporters ($1,000,000+/year)
(with funding for 2020 previously provided by Janssen Pharmaceuticals)
Champion Supporters ($250,000/year)
Donors (<$250,000/year)
Legacy supporters include: